Insmed Reports Second Quarter 2021 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Insmed (INSM) Misses Q2 EPS by 22c
August 5, 2021 8:12 AM EDTInsmed (NASDAQ: INSM) reported Q2 EPS of ($1.07), $0.22 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $45.4 million versus the consensus estimate of $43.72 million.
"Insmed made meaningful progress in the second quarter of 2021, with important achievements across our four pillars-ARIKAYCE, brensocatib,... More
